Log In
Print
BCIQ
Print
Print this Print this
 

Insugen R

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionShort-acting biosimilar recombinant human insulin
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today